Company / SG&A Expense
Artivion SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$226.5M
FY2025
5-year range
$141.1M / $226.5M
FY2021-FY2025
Trend
+24.8%
vs FY2024
Sector context
#101 of 158
Health Care
What the data says
At $226M, Artivion's sg&a expense ranks #58 of 158 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $74M in FY2016 to $226M in FY2025.
Based on SEC 10-K filings.
$226M in FY2025 with a 5-year CAGR of +10.0%.
Increased from $209M to $226M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- +10.0%
- 10-Year CAGR
- -
Sector benchmark
#58 of 158 in Health CareTop 36% of 158This company $226.5M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +10.0%, indicating consistent growth.
- In FY2025, sg&a expense increased 24.8% year-over-year.
- Ranks #101 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $226.5M | +24.8% |
| FY2024 | $181.5M | -13.2% |
| FY2023 | $209.0M | +48.1% |
| FY2022 | $141.1M | -1.3% |
| FY2021 | $143.0M | +1.7% |
| FY2020 | $140.6M | +38.9% |
| FY2019 | $101.2M | +10.6% |
| FY2018 | $91.5M | +22.2% |
| FY2017 | $74.9M | +1.6% |
| FY2016 | $73.8M | +8.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026